Compare UVE & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UVE | AMPH |
|---|---|---|
| Founded | 1990 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 957.6M | 971.8M |
| IPO Year | 1996 | 2005 |
| Metric | UVE | AMPH |
|---|---|---|
| Price | $39.10 | $18.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $40.00 | $28.38 |
| AVG Volume (30 Days) | 193.4K | ★ 495.1K |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.97% | N/A |
| EPS Growth | ★ 214.43 | N/A |
| EPS | ★ 1.88 | 0.14 |
| Revenue | ★ $1,603,915,000.00 | $719,887,000.00 |
| Revenue This Year | N/A | $6.90 |
| Revenue Next Year | $2.88 | $4.64 |
| P/E Ratio | ★ $20.98 | $123.57 |
| Revenue Growth | ★ 5.48 | N/A |
| 52 Week Low | $21.96 | $17.03 |
| 52 Week High | $41.96 | $31.26 |
| Indicator | UVE | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 56.46 | 35.85 |
| Support Level | $29.57 | $17.03 |
| Resistance Level | $41.96 | $20.08 |
| Average True Range (ATR) | 1.55 | 0.84 |
| MACD | -0.13 | -0.53 |
| Stochastic Oscillator | 50.85 | 13.97 |
Universal Insurance Holdings Inc is an insurance holding company. Through its subsidiaries, the company mainly offers property and casualty insurance and value-added insurance services. It develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners lines of business and performs all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The group offers the following types of personal residential insurance: homeowners, renters/tenants, condo unit owners, and dwelling/fire, through an independent agent network and online distribution channels across multiple states in the United States of America.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.